Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/ , based on November 2015 SEER data submission, posted to the SEER web site, April 2016. 2016.
2. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. An updated catalog of prostate cancer predictive tools. Cancer. 2008;113:3075–99.
3. Hernandez DJ, Nielsen ME, Han M, Partin AW. Contemporary evaluation of the Dʼamico risk classification of prostate cancer. Urology. 2007;70:931–5.
4. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–74.
5. Rodrigues G, Warde P, Pickles T, Crook J, Brundage M, Souhami L, Lukka H, Genitourinary Radiation Oncologists of C. Pre-treatment risk stratification of prostate cancer patients: a critical review. Can Urol Assoc J. 2012;6:121–7.